Statistics of Ewing Sarcoma

Executive Summary

Around 200 children and teens in the United States are diagnosed with an Ewing sarcoma. It constitutes 1% of all cancers in children and adolescents younger than 15 and 2% in teens aged 15 to 19 years. Almost all cases of Ewing sarcoma happen in white people. The overall 5-year survival rate for people having an Ewing tumor is 62%. Other factors such as a smaller-sized tumor, having a tumor located in an arm or leg, being younger than 10, and having normal levels of the enzyme lactate dehydrogenase in the blood evolve the fact that the survival rate can increase depending on the outcome of whether chemotherapy effectively treats cancer.

Statistics of Ewing Sarcoma

Every year, about 200 children and teens in the United States are diagnosed with an Ewing tumor (sarcoma). Ewing tumors form 1% of all cancers in children and adolescents younger than 15 and 2% in teens aged between 15 to 19 ​1​. About 50% of all Ewing sarcoma diagnoses are in people between 10 and 20. These tumors can also affect younger children and young adults in their 20s and 30s. Almost all cases of Ewing sarcoma happen in white people ​2​.

The 5-year survival rate reveals what percent of people live at least five years after the cancer is found. The 5-year survival rate is 75% for children younger than 15 and 58% for teens ages 15 to 19.

Survival rates also depend on various factors, including how far the tumor has spread. The overall 5-year survival rate for people having an Ewing tumor is 62% ​3​. If the tumor is found only in the area it began, the 5-year survival rate is 82%. If it has spread to the surrounding region, the 5-year survival rate is 67%. If the tumor has spread to distant areas at diagnosis (called metastasis), the 5-year survival rate is 39%.

Other factors have been linked to higher survival rates for all stages of Ewing tumors. These factors include having a smaller sized tumor, having a tumor located in an arm or leg, being younger than 10, and having normal levels of the enzyme lactate dehydrogenase in the blood. The survival rate can be higher depending on whether chemotherapy effectively treats cancer. 

It is noteworthy that statistics on the survival rates for people with Ewing Sarcoma are estimated.

References

  1. 1.
    Ebrahimpour A, Chehrassan M, Sadighi M, et al. The Survival and Incidence Rate of Ewing Sarcoma; a National Population-based Study in Iran (2008-2015). ABJS. Published online January 2020. doi:10.22038/abjs.2020.44095.2206
  2. 2.
    Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG. Ethnic and racial differences in patients with Ewing sarcoma. Cancer. Published online February 15, 2010:983-988. doi:10.1002/cncr.24865
  3. 3.
    Whelan J, McTiernan A, Cooper N, et al. Incidence and survival of malignant bone sarcomas in England 1979-2007. Int J Cancer. 2012;131(4):E508-17. doi:10.1002/ijc.26426